Brochure
More information from http://www.researchandmarkets.com/reports/1478832/
Patent Strategies - Effective Strategies for Extension of Product
Lifecycles and Combating Aggressive Generics Markets
Description: Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating
Aggressive Generics Markets
Summary
GBI Research’s new report, “Patent Strategies - Effective Strategies for Extension of Product
Lifecycles and Combating Aggressive Generics Markets”, provides in-depth analysis of various
patent protection strategies adopted by pharmaceutical companies for maximizing revenues returns
from the branded drugs. The report analyzes the effective patent strategies and provides you a
multi-strategy approach to defend your products from generics. It gives you a robust idea on
successful patent portfolio management. Furthermore, the report analyzes the patent strategies
that shape the global markets. This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by GBI Research’s
team of industry experts.
Scope
The scope of this report includes:
- Understanding of the R&D process and the necessity of patent protection.
- An overview of current patent protection mechanisms employed by pharmaceutical companies.
- Detailed study of pre-patent protection strategies with special emphasis on strategies which help
combating generic competition.
- Post-patent expiry strategies like authorized generics and orange book delisting with case studies.
- Inputs for customized patent strategy based on business situation.
- Case studies of successful patent strategies.
Reasons to buy
The report will enhance your decision making capability. It will provide you with:
- Build understanding of the key Patent strategies in place and the trends in the market
- Optimize your R&D pipeline through identification and understanding of the key strategy for your
drug.
- Identify the key players best positioned to capitalize on their products through effective
management of the lifecycle of their patented products.
- Develop effective business strategies related to Patents through the analytical insight gained from
case studies covering different strategies in the market.
- Understand the fit between the patent strategy and your product considering various factors
pertaining to the market, product and therapeutic area.
- Ensure success in patent portfolio management through the analysis of key success and failure
factors and the use of the framework for measuring performance.
Contents: 1 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Patent Strategies – Introduction 7
2.1 GBI Research Report Guidance 7
3 Patent Strategies – Need for Robust Patent Portfolio 8
3.1 Introduction 8
3.1.1 The Long and Uncertain R&D Process – Cost of Drug Development and Pipeline Risks 9
3.1.2 The Drug Lifecycle 9
3.2 Need to Optimize Returns from Successful Drugs 10
3.2.1 Peak Years of Patent Expiries 10
3.2.2 Declined Patent Applications by Top Pharmaceutical Companies 11
3.2.3 Declining Returns on R&D Investment 13
3.2.4 Patent Expiration of Blockbuster Drugs 14
3.2.5 Massive Decline in Sales – Dependence on Blockbuster Drugs 16
3.2.6 Penetration of Aggressive Generic Companies 17
3.2.7 Drought in the R&D Pipeline Products (Low R&D Productivity) 19
3.2.8 Stricter FDA Rules and Regulations for Drug Approval 21
3.2.9 Restriction on Pricing and Reimbursement of Originals 22
3.2.10 Conclusion 22
4 Patent Strategies – Overview of Patent Protection Methodology 23
4.1 Introduction 23
4.2 What is a Patent? 23
4.2.1 Effective Patent Life 23
4.2.2 Data Exclusivity Period 23
4.2.3 When Does a Patent Expire? Which Patent? 24
4.2.4 Patent Families – Extension of Patent Expiry 24
4.3 Patent Term Extensions 25
4.3.1 Supplementary Protection Certificates 25
4.3.2 Pediatric Exclusivity 27
4.4 Orphan Drug Legislation 28
4.4.1 Special Cases of Orphan Drug Exclusivity 29
4.5 Hatch-Waxman Amendments and Abbreviated New Drug Applications (ANDA) 30
4.5.1 First on the Market – ANDAs 30
4.5.2 Paragraph IV Challenges 31
4.5.3 Generic Companies are not actually in Favor of Low Prices – 180-Day Marketing Exclusivity 32
4.6 FDA Citizen Petitions 32
5 Patent Strategies – Pre-Patent Expiry Strategies 33
5.1 Introduction 33
5.2 Strategic Patenting/Patent Layering 33
5.2.1 Many Secondary Patents Provide No Legal Protection 33
5.3 Formulation Patents 34
5.3.1 Introducing Formulation Variants (Tablets, IVs, Syrups) 34
5.4 Improved Formulations 39
5.4.1 Extended/Controlled Release Versions 39
5.5 New Indications 44
5.5.1 Introduction 44
5.6 Probability of Generics Entry for a Drug 50
5.6.1 Introduction 50
5.7 Planning Rx-to-OTC Switch 50
5.7.1 Introduction 50
5.8 Store-Brand Generic 57
5.8.1 Introduction 57
5.9 Strategies That Failed 59
5.9.1 Introduction 59
5.10 Key Lessons 63
5.10.1 New Formulations, New Indications and Extended/Controlled Releases 63
5.10.2 Planned Rx-to-OTC Switch 63
5.10.3 Store-Brand Generic 63
5.10.4 Failed Strategies 64
6 Patent Strategies – Post Patent Expiry Strategies 65
6.1 Introduction 65
6.2 Authorized Generics 65
6.2.1 Case Study: GSK’s Paxil 65
6.2.2 Future of Authorized generics 65
6.3 Orange Book Listings and Delisting: New Controversies 66
6.3.1 Case Study: Merck’s Zocor 66
6.3.2 The Future of Delisting Strategy 66
6.4 Conclusion 67
7 Patent Strategies – Appendix 68
7.1 Market Definitions 68
7.2 Abbreviations 68
7.3 Research Methodology 69
7.3.1 Coverage 69
7.3.2 Secondary Research 69
7.3.3 Primary Research 69
7.3.4 Expert Panel Validation 70
7.4 Contact Us 70
7.5 Disclaimer 70
7.6 Sources 71
Ordering: Order Online - http://www.researchandmarkets.com/reports/1478832/
Order by Fax - using the form below
Order by Post - print the order form below and sent to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-
1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name: Patent Strategies - Effective Strategies for Extension of Product Lifecycles and
Combating Aggressive Generics Markets
Web Address: http://www.researchandmarkets.com/reports/1478832/
Office Code: OC8HQQPRNOQRY
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic -
EURO €2,687.00
Single User:
Electronic - Site
EURO €5,374.00
License:
Electronic -
EURO €8,061.00
Enterprisewide:
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card: American Express
Diners Club
Master Card
Visa
Cardholder's Name
Cardholder's Signature
Expiry Date
Card Number
CVV Number
Issue Date
(for Diners Club only)
Pay by check: Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Please transfer funds to:
Pay by wire transfer:
Account number 833 130 83
Sort code 98-53-30
Swift code ULSBIE2D
IBAN number IE78ULSB98533083313083
Bank Address Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World